drugset / Trial / NCT07240116
Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This single-center, randomized, open-label study will assess the relative bioavailability of 2 miricorilant (CORT118335) tablet formulations.
Timeline
- Start
- 2025-09-11
- Primary completion
- 2026-03-03
- Completion
- 2026-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miricorilant | Small molecule | 100 mg | Oral |
Indications
No indication recorded.